Fortnightly review - Update on male erectile dysfunction

[31] MEINHARDT W, 1996, INT J IMPOT RES, V8, P116

[32] MORALES A, 1995, UROL CLIN N AM, V165, P60

[33] ASSESSMENT AND TREATMENT OF IMPOTENCE [J]. MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (02) : 415 - 434

[34] Treatment of men with erectile dysfunction with transurethral alprostadil [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (01) : 1 - 7

[35] NITRIC-OXIDE RELEASE ACCOUNTS FOR THE BIOLOGICAL-ACTIVITY OF ENDOTHELIUM-DERIVED RELAXING FACTOR [J]. NATURE, 1987, 327 (6122) : 524 - 526

[36] REID K, 1987, LANCET, V2, P421

[37] IMPOTENCE AND DIABETES MELLITUS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 168 (05): : 498 - 500

[38] *TOMHS RES GROUP, 1996, EUR UROL S2, V30, P38

[39] WAGNER G, 1994, INT J IMPOT RES S1, V6, pD78

[40] Wagner G., 1981, IMPOTENCE PHYSL PSYC

[31] MEINHARDT W, 1996, INT J IMPOT RES, V8, P116

[32] MORALES A, 1995, UROL CLIN N AM, V165, P60

[33] ASSESSMENT AND TREATMENT OF IMPOTENCE [J]. MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (02) : 415 - 434

[34] Treatment of men with erectile dysfunction with transurethral alprostadil [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (01) : 1 - 7

[35] NITRIC-OXIDE RELEASE ACCOUNTS FOR THE BIOLOGICAL-ACTIVITY OF ENDOTHELIUM-DERIVED RELAXING FACTOR [J]. NATURE, 1987, 327 (6122) : 524 - 526

[36] REID K, 1987, LANCET, V2, P421

[37] IMPOTENCE AND DIABETES MELLITUS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 168 (05): : 498 - 500

[38] *TOMHS RES GROUP, 1996, EUR UROL S2, V30, P38

[39] WAGNER G, 1994, INT J IMPOT RES S1, V6, pD78

[40] Wagner G., 1981, IMPOTENCE PHYSL PSYC